
118.9K
Downloads
254
Episodes
Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization.
Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist consulting firms. Our host Raman is an entrepreneur, investor, bestselling author, speaker and long time industry insider.
Episodes

Friday Oct 17, 2025
The understated CDMO CCO
Friday Oct 17, 2025
Friday Oct 17, 2025
In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with JB Agnus, Chief Commercial Officer at Bora Pharmaceuticals.
Your host, Raman Sehgal, speaks with JB about the pharmaceutical and biotechnology supply chain, including:
How his global roles taught him the importance of bridging cultures
What attracted him to Bora Pharmaceuticals and the company’s remarkable trajectory
The value of intentionality, taking charge of your own career, and prioritising physical and mental wellness
What it really looks and feels like to be a CDMO CCO, and the realities of stepping up into the role
Why it matters not to conform to the norm and instead stay true to yourself
Prior to joining Bora, JB held senior leadership roles in business development at AGC Biologics, Ajinomoto Bio Pharma Services, Novasep, and Isochem. He holds a bachelor’s degree in organic chemistry from Université Paul Sabatier Toulouse III in Toulouse, France, and a master’s degree in chemical engineering from Centrale Méditerranée in Marseille, France.
Molecule to Market is sponsored by Bora Pharma, Charles River, and Lead Candidate. Please subscribe, tell your industry colleagues, and help us celebrate the value of the global life science outsourcing space. We’d also appreciate a positive rating!

No comments yet. Be the first to say something!